Fresenius Medical Care AG (FMCQF) Equity Income (2010 - 2026)

Fresenius Medical Care AG has reported Equity Income for 17 years, with the latest figure at $48.0 million in Q2 2026.

• On a quarterly basis, Equity Income rose 193.78% year-over-year to $48.0 million in Q2 2026; TTM through Jun 2026 was -$266.1 million, a 8.52% increase from a year earlier, with the FY2025 full-year figure at -$211.1 million, down 46.48% from the prior year.
• Equity Income was $48.0 million for Q2 2026 at Fresenius Medical Care AG, up from -$48.4 million in the prior quarter.
• The five-year high for Equity Income was $48.0 million in Q2 2026, with the low at -$211.1 million in Q4 2025.
• Average Equity Income over 5 years is -$54.4 million, with a median of -$46.8 million recorded in 2026.
• The sharpest annual moves came in 2023 and 2026: Equity Income sank 154.35% in 2023, then jumped 193.78% in 2026.
• Over 5 years, Equity Income stood at -$67.9 million in 2022, then sank by 92.96% to -$131.0 million in 2023, then dropped by 9.99% to -$144.1 million in 2024, then slumped by 46.48% to -$211.1 million in 2025, then jumped by 122.71% to $48.0 million in 2026.
• The last three Equity Income figures came in at $48.0 million (Q2 2026), -$48.4 million (Q1 2026), and -$211.1 million (Q4 2025), per Business Quant data.